Browsing Faculté de pharmacie by Author "Jourdi, Georges"

Now showing items 1-3 of 3

  • Antiplatelet therapy for atherothrombotic disease in 2022 : from population to patient-centered approaches 

    Jourdi, Georges; Godier, Anne; Lordkipanidzé, Marie; Marquis-Gravel, Guillaume; Gaussem, Pascale (Frontiers Media, 2022-01-28)
    Antiplatelet agents, with aspirin and P2Y12 receptor antagonists as major key molecules, are currently the cornerstone of pharmacological treatment of atherothrombotic events including a variety of cardio- and cerebro-vascular as well as peripheral ...

  • Antiplatelet therapy in atherothrombotic diseases : similarities and differences across guidelines 

    Jourdi, Georges; Marquis-Gravel, Guillaume; Martin, Anne-Céline; Lordkipanidzé, Marie; Godier, Anne; Gaussem, Pascale (Frontiers media, 2022-04-27)
    Antiplatelet therapy, mainly consisting of aspirin and P2Y12 receptor antagonists, is the cornerstone of the pharmacological treatment and prevention of atherothrombotic diseases. Its use, especially in secondary cardiovascular prevention, has ...

  • Current and novel antiplatelet therapies for the treatment of cardiovascular diseases 

    Jourdi, Georges; Lordkipanidzé, Marie; Philippe, Aurélien; Bachelot-Loza, Christilla; Gaussem, Pascale (MDPI, 2021-12-03)
    Over the last decades, antiplatelet agents, mainly aspirin and P2Y12 receptor antagonists, have significantly reduced morbidity and mortality associated with arterial thrombosis. Their pharmacological characteristics, including pharmacokinetic/pharmacodynamics ...